Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Medications such as semaglutide (Wegovy) and liraglutide (Saxenda) are licensed for weight management, while other GLP-1 receptor agonists like dulaglutide (Trulicity) are licensed only for type 2 diabetes in the UK
Clinical Trials and Evidence: STEP Program The Semaglutide Treatment Effect in People with Obesity (STEP) trials provide the strongest evidence for Semaglutide for Obesity This evidence shows that Semaglutide for Obesity is not only effective but also sustainable for long-term management
The half-life of PYY analogs can be extended by PEGylation (polyethylene glycol modification), fatty acid chain modification, or conjugation with albumin (157)
Warning : Consult your healthcare professional before use if pregnant, nursing, taking medications, or for any use by minors
